MKPs, and particularly DUSP1 and DUSP6, have been proposed as cancer biomarkers, since aberrant expression of these phosphatases has been found in a wide variety of human cancers, including neuroblastoma. The gene discussed is DUSP1; the disease is neuroblastoma.